Cargando…

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

BACKGROUND: Recently published results from a large randomized trial (Canadian Cervical Cancer Screening Trial study group) suggest that human papillomavirus testing followed by Pap smear-based triage for human papillomavirus positive women may be an effective way to screen women for cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulasingam, Shalini L, Rajan, Raghu, St Pierre, Yvan, Atwood, C Victoria, Myers, Evan R, Franco, Eduardo L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780455/ https://www.ncbi.nlm.nih.gov/pubmed/19900264 http://dx.doi.org/10.1186/1741-7015-7-69

Ejemplares similares

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2008)

Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system
por: Chow, I H-I, et al.
Publicado: (2010)

Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination
por: Teoh, Deanna, et al.
Publicado: (2022)

Lower cost strategies for triage of human papillomavirus DNA-positive women
por: Qiao, You-Lin, et al.
Publicado: (2014)

Prevalence of human papillomavirus infection in abnormal pap smears
por: Mishra, Jaya, et al.
Publicado: (2023)

Geospatial patterns of human papillomavirus vaccine uptake in Minnesota
por: Nelson, Erik J, et al.
Publicado: (2015)

Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women
por: Assoumou, Samira Zoa, et al.
Publicado: (2015)

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
por: Reques, Laura, et al.
Publicado: (2021)

Human papillomavirus variants among Inuit women in northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2015)

Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
por: Goyette, Alexandra, et al.
Publicado: (2021)

Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011–2018
por: Zhao, Ran, et al.
Publicado: (2023)

PIII-1 Frequency and genotyping of human papillomavirus in pap smear samples
por: Simsek, B., et al.
Publicado: (2009)

Health care personnel’s perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study
por: Xiong, Serena, et al.
Publicado: (2022)

MicroRNA Detection in Cervical Exfoliated Cells as a Triage for Human Papillomavirus–Positive Women
por: Tian, Qifang, et al.
Publicado: (2014)

Cost and logistics of alternative roll-out options for implementing human papillomavirus testing as a triage in cervical screening: results of the sentinel sites study
por: Legood, R, et al.
Publicado: (2012)

Estimation of Geographic Variation in Human Papillomavirus Vaccine Uptake in Men and Women: An Online Survey Using Facebook Recruitment
por: Nelson, Erik J, et al.
Publicado: (2014)

Granulomas on cervical Pap smear: “Forget me not”
por: Jindal, Akriti, et al.
Publicado: (2023)

Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus–Positive Women
por: Chu, Boliang, et al.
Publicado: (2023)

The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada
por: Jiang, Ying, et al.
Publicado: (2013)

A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images
por: William, Wasswa, et al.
Publicado: (2019)

Knowledge about Cervical Cancer and Pap Smear and the Factors Influencing the Pap test Screening among Women
por: Ashtarian, Hossein, et al.
Publicado: (2017)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

Women’s perception of cervical cancer pap smear screening
por: Siseho, Kristine N., et al.
Publicado: (2022)

Validity and acceptance of self vs conventional sampling for the analysis of human papillomavirus and Pap smear
por: Gibert, M. J., et al.
Publicado: (2023)

Preventive Pap-smears: balancing costs, risks and benefits.
por: van Ballegooijen, M., et al.
Publicado: (1992)

The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies
por: Guo, Yanli, et al.
Publicado: (2014)

The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan
por: Fujiwara, Hiroyuki, et al.
Publicado: (2019)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

Online media scans: Applying systematic review techniques to assess statewide human papillomavirus vaccination activities
por: Groene, Emily A., et al.
Publicado: (2019)

Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients
por: Kim, Hye-Sun, et al.
Publicado: (2016)

4223 Changes in positive predictive value of cervical cytology following HPV vaccination
por: Teoh, Deanna, et al.
Publicado: (2020)

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2019)

Screening for Cervical Cancer Using Automated Analysis of PAP-Smears
por: Bengtsson, Ewert, et al.
Publicado: (2014)

Prevalence of Cervical-Vaginal Infections in the Pap-Smear Samples in Iran
por: Maria, Cheraghi, et al.
Publicado: (2014)

Cytological Features Associated with Ureaplasma Urealyticum in Pap Cervical Smear
por: Okodo, Mitsuaki, et al.
Publicado: (2017)

Persistent racial disparities in cervical cancer screening with Pap test
por: McDaniel, Cassidi C., et al.
Publicado: (2021)

Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
por: Severini, Alberto, et al.
Publicado: (2013)

Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population
por: Gardella, Barbara, et al.
Publicado: (2021)

Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria
por: Hyacinth, Hyacinth I., et al.
Publicado: (2012)

Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy
por: Trottier, Helen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_49hb8kcqhorf2hou6dcqbta0mp